High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas

Immunotherapy has demonstrated encouraging clinical benefits in patients with advanced breast carcinomas and Programmed death ligand 1 (PD-L1) expression has been proposed as an immunotherapy biomarker. Challe...

Source: Diagnostic Pathology - May 11, 2020 Category: Pathology Authors: Ping Mei, C. Eric Freitag, Lai Wei, Yunxiang Zhang, Anil V. Parwani and Zaibo Li Tags: Research Source Type: research